این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Public Health، جلد ۵۲، شماره ۶، صفحات ۱۱۵۰-۱۱۶۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Auxiliary Diagnosis and Prognostic Value of Dehydrogenase/Reductase 2 (DHRS2) in Various Tumors
چکیده انگلیسی مقاله Background: As the most convenient and commonly used for clinical diagnosis, cancer biomarker has been widely used in the auxiliary diagnosis of tumors, the observation of curative effect, the judgment of prognosis, and the monitoring of the disease. Methods: Pan-cancer analysis was used to validate the value of Dehydrogenase/Reductase 2 (DHRS2) as a tumor prognostic marker in various tumors. The relationship of DHRS2 to TMB and MSI was used to explain the effect of DHRS2 on genomic instability. Online cbioportal was used to analyze DHRS2 mutations in tumors. Finally, 33 clinical tumor samples were collected in 2021 who were enrolled into the Affiliated Lianyungang Oriental Hospital of Xuzhou Medical University, to verify the expression and diagnostic prognostic value of DHRS2. Results: The expression of DHRS2 was up-regulated in a variety of tumors and had adverse effects on the overall survival, disease-free interval, and progression-free interval of tumor patients. DHRS2 was associated with tumor genome instability, confirming that DHRS2 was correlated with tumorigenesis. In addition, DHRS2 had different mutation sites in various tumors. DHRS2 was up-regulated and was a poor prognosis biomarker in clinical tumor samples. Conclusion: DHRS2 was aberrantly expressed in tumors and has diagnostic prognostic value.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Zhongwu An
Clinical Laboratory, The Affiliated Lianyungang Oriental Hospital, Xuzhou Medical University, Jiang Su, China


| Weibo Bo
Clinical Laboratory, The Affiliated Lianyungang Oriental Hospital, Xuzhou Medical University, Jiang Su, China


| Jibao Qin
Clinical Laboratory, The Affiliated Lianyungang Oriental Hospital, Xuzhou Medical University, Jiang Su, China


| Ling Jiang
Clinical Laboratory, The Affiliated Lianyungang Oriental Hospital, Xuzhou Medical University, Jiang Su, China


| Jie Jiang
Department of Pharmacy, The Affiliated Lianyungang Oriental Hospital, Xuzhou Medical University, Jiang Su, China
نشانی اینترنتی https://ijph.tums.ac.ir/index.php/ijph/article/view/29734
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات